Hydroxychloroquine and Potential Drug Interactions in Older Adults.
作者信息
Velasco-González Verónica, Fernández-Araque Ana, Sainz-Gil Maria, Jimeno Natalia, Martín Luis H, Verde Zoraida
机构信息
Department of Nursery, University of Valladolid, Valladolid, Spain.
Recognized research group "Pharmacogenetics, Cancer Genetics, Genetic Polymorphisms and Pharmacoepidemiology", University of Valladolid, Valladolid, Spain.
出版信息
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):679-681. doi: 10.1016/j.arbr.2020.06.002. Epub 2020 Oct 1.
Abstract
摘要
相似文献
1
Hydroxychloroquine and Potential Drug Interactions in Older Adults.羟氯喹与老年人潜在的药物相互作用
Arch Bronconeumol (Engl Ed). 2020 Oct;56(10):679-681. doi: 10.1016/j.arbr.2020.06.002. Epub 2020 Oct 1.
2
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients.羟氯喹啉与阿奇霉素联合治疗COVID-19患者的安全性概况。
Int J Antimicrob Agents. 2021 Jan;57(1):106236. doi: 10.1016/j.ijantimicag.2020.106236.
3
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.羟氯喹啉和阿奇霉素治疗新型冠状病毒肺炎的临床疗效及安全性概况
Int J Antimicrob Agents. 2021 Jan;57(1):106242. doi: 10.1016/j.ijantimicag.2020.106242.
4
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.羟氯喹和阿奇霉素用于治疗新型冠状病毒肺炎：重新审视一项开放标签非随机临床试验的结果
Int J Antimicrob Agents. 2021 Jan;57(1):106243. doi: 10.1016/j.ijantimicag.2020.106243.
5
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.一项评估法匹拉韦和羟氯喹联合治疗中重度 COVID-19 住院成人的疗效和安全性的随机对照研究：研究方案的结构化总结。
Trials. 2020 Oct 31;21(1):904. doi: 10.1186/s13063-020-04825-x.
6
Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.羟氯喹联合阿奇霉素作为 COVID-19 患者潜在治疗方法：安全性概况、药物相互作用以及毒性管理。
Microb Drug Resist. 2021 Mar;27(3):281-290. doi: 10.1089/mdr.2020.0232.
7
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.羟氯喹、阿奇霉素和环索奈德三联疗法治疗 COVID-19 肺炎。
J Microbiol Immunol Infect. 2021 Feb;54(1):109-112. doi: 10.1016/j.jmii.2020.09.003. Epub 2020 Oct 5.
8
Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.羟氯喹、瑞德西韦和地塞米松在美国 COVID-19 住院成人患者中的使用：一项回顾性队列研究。
Ann Intern Med. 2021 Oct;174(10):1395-1403. doi: 10.7326/M21-0857. Epub 2021 Aug 17.
9
The Rediscovery of Hydroxychloroquine in Allergic Diseases in the COVID-19 Era.羟氯喹在新冠疫情时代过敏性疾病中的重新发现
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):85-86. doi: 10.18176/jiaci.0575. Epub 2020 May 31.
10
Hydroxychloroquine and COVID-19: The endgame!羟氯喹与2019冠状病毒病：终局！
Therapie. 2023 Jul-Aug;78(4):343-344. doi: 10.1016/j.therap.2023.06.003. Epub 2023 Jun 7.
引用本文的文献
1
Drug-Drug Interactions of Hydroxychloroquine and Chloroquine in Older Patients with COVID-19 during the First Pandemic Waves: The GeroCovid Observational Study.新冠疫情第一波期间老年COVID-19患者中羟氯喹和氯喹的药物相互作用：老年COVID观察性研究
Reports (MDPI). 2024 May 23;7(2):42. doi: 10.3390/reports7020042.
2
Chronic Dermatographic Urticaria Secondary to Systemic Lupus Erythematosus.系统性红斑狼疮继发慢性皮肤划痕症性荨麻疹
Cureus. 2024 Jun 25;16(6):e63109. doi: 10.7759/cureus.63109. eCollection 2024 Jun.
3
Risk Factors for QT Prolongation in Patients with Chronic Hydroxychloroquine Use.长期使用羟氯喹患者QT间期延长的危险因素
Acta Cardiol Sin. 2022 Nov;38(6):723-735. doi: 10.6515/ACS.202211_38(6).20220415A.
4
Knowledge and Compliance of Hydroxychloroquine Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Indian Health-Care Workers.印度医护人员对羟氯喹预防严重急性呼吸综合征冠状病毒2感染的认知与依从性
J Res Pharm Pract. 2022 Aug 18;11(1):33-39. doi: 10.4103/jrpp.jrpp_50_21. eCollection 2022 Jan-Mar.
5
Potential interactions between antineoplastic agents and medicines used to treat Covid-19.抗肿瘤药物与用于治疗 COVID-19 药物的潜在相互作用。
J Oncol Pharm Pract. 2022 Dec;28(8):1737-1748. doi: 10.1177/10781552211040494. Epub 2021 Oct 12.
本文引用的文献
1
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
2
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro.羟氯喹啉是氯喹毒性较低的衍生物，在体外可有效抑制严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染。
Cell Discov. 2020 Mar 18;6:16. doi: 10.1038/s41421-020-0156-0. eCollection 2020.
3
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒（2019 - 新冠病毒）。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
4
Physical Performance and Quality of Life in Older Adults: Is There Any Association between Them and Potential Drug Interactions in Polymedicated Octogenarians.老年人的身体机能表现和生活质量：它们与 80 岁以上多药物治疗患者潜在药物相互作用之间有何关联？
Int J Environ Res Public Health. 2019 Oct 29;16(21):4190. doi: 10.3390/ijerph16214190.
5
[Effectiveness, safety and costs of stroke prevention in non-valvular auricular fibrillation. Study of cohorts matched by Propensity score].[非瓣膜性心房颤动卒中预防的有效性、安全性及成本。倾向评分匹配队列研究]
Aten Primaria. 2020 Mar;52(3):176-184. doi: 10.1016/j.aprim.2019.06.002. Epub 2019 Sep 21.
6
Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence.评估老年人使用抗抑郁药相关的QTc延长风险：证据综述
Ther Adv Drug Saf. 2018 Jun;9(6):297-308. doi: 10.1177/2042098618772979. Epub 2018 May 4.
7
Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment.老年人的多重用药——当好药导致不良后果时：一个值得汲取教训的时刻。
JAMA Intern Med. 2017 Jun 1;177(6):871. doi: 10.1001/jamainternmed.2017.0911.
8
Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.直接作用口服抗凝剂的实验室与临床监测：临床医生须知
Pharmacotherapy. 2017 Feb;37(2):236-248. doi: 10.1002/phar.1884. Epub 2017 Feb 3.
9
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials.药物相互作用和QT间期延长作为一种常见的心脏效应评估——临床试验综述
BMC Pharmacol Toxicol. 2016 Mar 10;17:12. doi: 10.1186/s40360-016-0053-1.
10
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.胺碘酮致肺毒性——1 例致死病例报告及文献复习。
Cardiovasc Drugs Ther. 2013 Jun;27(3):247-54. doi: 10.1007/s10557-013-6446-0.
Zotero 插件